RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU5F0CC8A7071A2EAE

https://w3id.org/ripe/ripe-kg/author/RIPEAU5F0CC8A7071A2EAE
SubjectPredicateObject
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type node1
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type rdfs:Resource
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type owl:Thing
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type prov:Person
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type foaf:Person
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao owl:sameAs https://semopenalex.org/author/A5025095801
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao foaf:familyName Zhao
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao foaf:givenName Xingli
ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao foaf:name Xingli Zhao
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial dcterms:creator ripekg:author/RIPEAU5F0CC8A7071A2EAEXingli Zhao